✦ LIBER ✦

Cost-effectiveness analysis of two vacuum-assisted breast biopsy systems: Mammotome and Vacora

✍ Scribed by C.A. Pistolese; A.M. Ciarrapico; F. della Gatta; T. Perretta; E. Cossu; F. Bolacchi; E. Bonanno; G. Simonetti

Book ID: 107387778
Publisher: Springer
Year: 2009
Tongue: Italian
Weight: 384 KB
Volume: 114
Category: Article
ISSN: 0033-8362
DOI: 10.1007/s11547-009-0404-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and cost-effectiveness of stere

Efficacy and cost-effectiveness of stereotactic vacuum-assisted core biopsy of nonpalpable breast lesions: analysis of 602 biopsies performed over 5 years

✍ A. Luparia; M. Durando; P. Campanino; E. Regini; D. Lucarelli; A. Talenti; G. Ma 📂 Article 📅 2011 🏛 Springer 🌐 Italian ⚖ 347 KB

Diagnostic value of vacuum-assisted brea

Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review

✍ Ying-Hua Yu; Chi Liang; Xi-Zi Yuan 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 350 KB

The palpable breast nodule: A cost-effec

The palpable breast nodule: A cost-effectiveness analysis of alternate diagnostic approaches: The role of the needle aspiration biopsy

✍ Leopold G. Koss 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

Ultrasound-Guided Vacuum-Assisted Breast

Ultrasound-Guided Vacuum-Assisted Breast Biopsy System for Diagnosis and Minimally Invasive Excision of Intraductal Papilloma Without Nipple Discharge

✍ Hu Wei; Fan Jiayi; Zhang Qinping; Shi Junyi; Shen Yuan; Li Li; Su Dongwei; Qing 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 127 KB

Evaluation of Breast Imaging Reporting a

Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice

✍ Angela Mendez; Fernando Cabanillas; Miguel Echenique; Keyvan Malekshamran; Iris 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract ## BACKGROUND Breast Imaging Reporting and Data System (BI‐RADS) Category 3 represents ‘probably benign’ mammographic abnormalities requiring close follow‐up, but biopsies sometimes are performed on Category 3 abnormalities. Controversy exists as to when these biopsies are justified. T